iShares Biotechnology ETF Rating $117.16 -6.63 (-5.36%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$117.22 +0.06 (+0.05%) As of 04/4/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.68Holdings in IBB have an aggregate rating of Moderate Buy based on 783 analyst ratings issued in the past year covering 49 companies (83.2% of the portfolio).IBB Aggregate Price Target$117.16High Prediction$117.16Average Prediction$117.16Low Prediction$117.16Holdings in IBB have an aggregate price target of $117.16 and a range of $117.16 to $117.16 covering 49 companies (83.2% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.89%VRTXVertex Pharmaceuticals$474.62-1.9%3.7546 of 5 stars2.65$509.17 7.3%26Analyst ForecastNews CoveragePositive NewsHigh Trading Volume8.86%AMGNAmgen$294.39-5.0%4.2912 of 5 stars2.48$314.04 6.7%23News CoveragePositive News8.67%GILDGilead Sciences$107.25-4.6%4.4561 of 5 stars2.72$105.12 -2.0%29Analyst RevisionPositive News7.38%REGNRegeneron Pharmaceuticals$573.45-6.1%4.733 of 5 stars2.76$966.88 68.6%25Short Interest ↑Analyst RevisionHigh Trading Volume3.72%ALNYAlnylam Pharmaceuticals$235.74-10.1%4.553 of 5 stars2.77$316.25 34.2%26Analyst ForecastAnalyst RevisionPositive NewsHigh Trading Volume3.35%IQVIQVIA$154.63-7.8%4.8053 of 5 stars2.86$249.05 61.1%21Positive News2.85%ARGXargenx$555.11-5.9%3.0694 of 5 stars2.91$687.00 23.8%23News CoveragePositive News2.59%MTDMettler-Toledo International$1,021.97-6.7%4.0058 of 5 stars2.11$1,380.50 35.1%9News CoveragePositive NewsHigh Trading Volume2.35%WATWaters$324.57-6.0%4.1985 of 5 stars2.61$401.31 23.6%18Analyst RevisionHigh Trading Volume2.18%BIIBBiogen$122.98-5.9%4.8355 of 5 stars2.42$213.33 73.5%31Analyst DowngradeNews CoveragePositive NewsHigh Trading Volume2.03%NTRANatera$133.87-3.5%3.6189 of 5 stars3.00$178.12 33.1%16Insider TradeNews CoveragePositive NewsGap DownHigh Trading Volume1.72%BNTXBioNTech$88.05-4.3%2.685 of 5 stars2.89$143.44 62.9%18Analyst ForecastAnalyst RevisionGap Down1.67%ONCBeigene$238.51-9.8%1.9768 of 5 stars3.00$310.00 30.0%3Insider TradeNews CoverageGap Down1.55%UTHRUnited Therapeutics$292.46-4.8%4.8614 of 5 stars2.67$388.25 32.8%12Positive News1.49%INSMInsmed$69.18-5.7%4.2551 of 5 stars3.00$94.00 35.9%16Positive NewsGap Down1.46%BMRNBioMarin Pharmaceutical$60.26-10.7%4.8701 of 5 stars2.71$94.00 56.0%24Analyst DowngradeNews CoveragePositive News1.38%ILMNIllumina$74.16-3.0%4.7013 of 5 stars2.48$140.90 90.0%21Positive News1.37%INCYIncyte$60.58-3.0%4.6053 of 5 stars2.21$74.88 23.6%19Positive News1.15%EXELExelixis$34.57-5.8%4.4247 of 5 stars2.50$37.59 8.7%20Positive News1.14%NBIXNeurocrine Biosciences$95.65-7.0%4.8134 of 5 stars2.83$163.52 71.0%23Analyst ForecastNews CoverageGap DownHigh Trading Volume1.02%GMABGenmab A/S$18.39-4.4%3.7541 of 5 stars2.69$41.33 124.8%13Analyst DowngradeGap DownHigh Trading Volume1.01%MRNAModerna$25.11-2.4%4.2066 of 5 stars2.04$59.00 135.0%24Gap DownHigh Trading Volume0.98%TECHBio-Techne$51.72-5.7%4.7973 of 5 stars2.56$81.25 57.1%9Analyst UpgradeShort Interest ↑Positive NewsHigh Trading Volume0.87%MEDPMedpace$287.11-5.6%4.6821 of 5 stars2.38$376.30 31.1%13Short Interest ↓News CoveragePositive NewsGap DownHigh Trading Volume0.86%HALOHalozyme Therapeutics$59.77-3.5%4.1259 of 5 stars2.60$62.78 5.0%10News CoveragePositive News0.82%CRLCharles River Laboratories International$136.95-2.9%4.677 of 5 stars1.94$189.77 38.6%16News CoveragePositive NewsGap DownHigh Trading Volume0.74%RGENRepligen$111.94-8.0%4.643 of 5 stars2.57$178.64 59.6%14Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume0.72%ASNDAscendis Pharma A/S$142.67-4.9%2.9345 of 5 stars2.93$204.64 43.4%14News CoveragePositive NewsGap Down0.70%MDGLMadrigal Pharmaceuticals$314.39-3.9%3.3508 of 5 stars2.80$378.44 20.4%10Positive NewsGap Down0.63%BPMCBlueprint Medicines$81.68-6.2%2.6323 of 5 stars2.70$124.95 53.0%23News CoveragePositive NewsHigh Trading Volume0.61%RVMDRevolution Medicines$31.32-4.7%4.0667 of 5 stars3.08$65.23 108.3%13Analyst ForecastNews CoveragePositive NewsGap Down0.60%SRPTSarepta Therapeutics$54.43-7.1%4.7583 of 5 stars2.83$163.18 199.8%23Analyst UpgradeOptions VolumeNews CoverageHigh Trading Volume0.58%BBIOBridgeBio Pharma$31.37-7.9%4.5391 of 5 stars2.92$52.64 67.8%12Insider TradeGap Down0.57%ALKSAlkermes$30.06-5.1%4.8009 of 5 stars2.69$39.38 31.0%13Positive NewsGap Down0.54%CYTKCytokinetics$37.36-7.8%3.8773 of 5 stars2.94$82.00 119.5%18Analyst ForecastHigh Trading Volume0.51%ROIVRoivant Sciences$9.46-5.5%2.2539 of 5 stars3.00$17.50 85.0%40.51%ADMAADMA Biologics$18.01-7.4%2.0749 of 5 stars3.25$22.50 24.9%4Positive NewsGap Down0.51%IONSIonis Pharmaceuticals$27.09-5.0%4.1748 of 5 stars2.67$58.37 115.5%21Analyst ForecastGap Down0.50%KRYSKrystal Biotech$171.30-3.8%4.7913 of 5 stars3.00$220.00 28.4%8Analyst RevisionNews CoveragePositive NewsGap Down0.49%AXSMAxsome Therapeutics$98.86-8.4%4.6261 of 5 stars3.00$167.64 69.6%15Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap Down0.48%LEGNLegend Biotech$32.01-2.6%2.5088 of 5 stars2.92$79.00 146.8%12Short Interest ↓News CoveragePositive NewsGap Down0.45%BRKRBruker$36.46-3.2%4.6926 of 5 stars2.55$70.50 93.4%11News CoveragePositive NewsGap DownHigh Trading Volume0.44%PCVXVaxcyte$31.60+3.4%2.4845 of 5 stars3.10$136.50 332.0%10Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume0.41%PTCTPTC Therapeutics$43.24-7.5%3.8503 of 5 stars2.53$63.77 47.5%15News CoverageGap Down0.41%TEMTempus AI$42.58-7.8%2.5675 of 5 stars2.50$61.18 43.7%12Insider TradeShort Interest ↑Gap DownHigh Trading Volume0.36%RNAAvidity Biosciences$26.57-5.4%2.4591 of 5 stars3.00$66.69 151.0%13Insider TradeNews CoverageGap Down0.35%SWTXSpringWorks Therapeutics$39.09-9.2%1.8296 of 5 stars3.00$73.20 87.3%5News CoveragePositive NewsGap DownHigh Trading Volume0.35%RAREUltragenyx Pharmaceutical$32.43-7.7%4.3111 of 5 stars2.93$92.79 186.1%14News CoveragePositive NewsGap Down0.35%NUVLNuvalent$65.74-3.8%2.2088 of 5 stars2.91$113.44 72.6%11News CoveragePositive NewsGap Down This page (NASDAQ:IBB) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
